The Effect of Alexithymia, Metacognitive Beliefs and Self-Efficacy on Disability in Patients With Schizophrenia: A Cross-Sectional Study

Basit Öğe Kaydı
dc.contributor.authorPolat, Hatice
dc.contributor.authorUgur, Kerim
dc.contributor.authorSun, Tunahan
dc.date.accessioned2026-06-19T06:39:21Z
dc.date.available2026-06-19T06:39:21Z
dc.date.issued2026
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractIntroduction Schizophrenia is a chronic mental disorder and one of the leading causes of disability worldwide, with greater levels of disability being associated with lower general self-efficacy. Reducing disability and enhancing self-sufficiency in individuals diagnosed with schizophrenia are among the primary goals of treatment and care. Aim This study aimed to examine the effects of alexithymia and metacognitive beliefs on self-efficacy levels and disability in individuals diagnosed with schizophrenia. Methods The study was conducted with 145 individuals under the age of 30 (67 individuals diagnosed with schizophrenia and 78 healthy controls) using a descriptive and correlational design. Data were collected using a sociodemographic data form, the Toronto Alexithymia Scale (TAS-20), the Metacognition Questionnaire (MCQ-30), the General Self-Efficacy Scale (GSES) and the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). Results Compared to the control group, the patient group demonstrated significantly higher TAS-20, MCQ-30 and WHODAS 2.0 scores, and significantly lower GSES scores (p < 0.05). The patients' total MCQ-30 scores were significantly associated with both WHODAS 2.0 and GSES scores (p < 0.05); however, TAS-20 did not mediate the relationship between MCQ-30 and WHODAS 2.0 (p > 0.05), whereas it showed a significant mediating effect in the relationship between MCQ-30 and GSES (p < 0.05). Discussion Patients exhibited higher disability and lower general self-efficacy than the control group. Cognitive-behavioural and metacognitive therapeutic approaches targeting alexithymia may contribute to improved functioning and reduced disability in individuals with schizophrenia. Implications for Practice The findings improve understanding of factors related to disability and diminished general self-efficacy in individuals with schizophrenia and may inform the development of targeted psychosocial interventions. Relevance Statement Self-efficacy and disability are key determinants of recovery in schizophrenia. By demonstrating the roles of alexithymia and metacognitive beliefs, this study provides a conceptual framework to guide clinical practice and supportive care strategies.
dc.identifier.doi10.1111/jpm.70126
dc.identifier.endpage527
dc.identifier.issn1351-0126
dc.identifier.issn1365-2850
dc.identifier.issue3
dc.identifier.pmid41891428
dc.identifier.scopus2-s2.0-105034197827
dc.identifier.scopusqualityQ1
dc.identifier.startpage516
dc.identifier.urihttps://doi.org/10.1111/jpm.70126
dc.identifier.urihttps://hdl.handle.net/20.500.12899/5556
dc.identifier.volume33
dc.identifier.wosWOS:001724748700001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofJournal of Psychiatric and Mental Health Nursing
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20260612
dc.subjectAlexithymia
dc.subjectDisability
dc.subjectMetacognitive Belief
dc.subjectSchizophrenia
dc.subjectSelf-Efficacy
dc.titleThe Effect of Alexithymia, Metacognitive Beliefs and Self-Efficacy on Disability in Patients With Schizophrenia: A Cross-Sectional Study
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu